Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ARRY-382 |
Synonyms | |
Therapy Description |
ARRY-382 is a small molecule inhibitor of CSF1R, which potentially leads to decreased growth of CSF1R over expressing tumor cells (PMID: 29872489). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ARRY-382 | CSF1R Inhibitor 28 | ARRY-382 is a small molecule inhibitor of CSF1R, which potentially leads to decreased growth of CSF1R over expressing tumor cells (PMID: 29872489). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|